Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07134972) titled 'The Effect of Ozone Treatment on Coronary Flow Reserve in Patients With Heart Failure Having Reduced Ejection Fraction' on Aug. 14.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Ekrem Bilal Karaayvaz
Condition:
Heart Failure and Reduced Ejection Fraction
Intervention:
Drug: Ozone treatment
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: January 14, 2024
Target Sample Size: 60
Countries of Recruitment:
Turkey
To know more, visit https://cli...